Fresh Rounds

Typewriter Therapeutics, Inc. funding

Typewriter Therapeutics, Inc., a biotechnology company based in Cambridge, MA (founded 2022), filed a Form D with the SEC on September 21, 2026 and reported $56.3M raised.

Amount raised$56.3M
Offering size$56.3M
Filed with the SECSeptember 21, 2026
First saleJanuary 8, 2026
IndustryBiotechnology
SecuritiesEquity
LocationCambridge, MA
Founded2022
Entity typeCorporation
Investors so far6
Minimum investment—
Revenue rangeDecline to Disclose

Other health care rounds in Massachusetts